These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7085831)

  • 1. Rapid estimation of diflunisal in plasma and urine by high-performance liquid chromatography and a comparison with a fluorometric method.
    Balali-Mood M; King IS; Prescott LF
    J Chromatogr; 1982 Apr; 229(1):234-40. PubMed ID: 7085831
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid high-performance liquid chromatographic method for the quantitative determination of diflunisal in plasma.
    Van Loenhout JW; Ketelaars HC; Gribnau FW; Van Ginneken CA; Tan Y
    J Chromatogr; 1980 Jun; 182(3-4):487-91. PubMed ID: 7391195
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of diflunisal in human plasma and urine by fast high-performance liquid chromatography.
    Schwartz M; Chiou R; Stubbs RJ; Bayne WF
    J Chromatogr; 1986 Aug; 380(2):420-4. PubMed ID: 3760071
    [No Abstract]   [Full Text] [Related]  

  • 4. High-performance liquid chromatographic analysis of diflunisal in plasma and urine: application to pharmacokinetic studies in two normal volunteers.
    Ray JE; Day RO
    J Pharm Sci; 1983 Dec; 72(12):1403-5. PubMed ID: 6663474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid reversed-phase high-performance liquid chromatographic assay of diflunisal in biological fluids.
    Midskov C
    J Chromatogr; 1983 Dec; 278(2):439-44. PubMed ID: 6668326
    [No Abstract]   [Full Text] [Related]  

  • 6. Steady-state disposition of diflunisal: once- versus twice-daily administration.
    Mojaverian P; Rocci ML; Swanson BN; Vlasses PH; Chremos AN; Lin JH; Yeh JC; Ferguson RK
    Pharmacotherapy; 1985; 5(6):336-9. PubMed ID: 3841206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diflunisal significantly interferes with salicylate measurements by FPIA-TDx and UV-VIS aca methods.
    Sarma L; Wong SH; DellaFera S
    Clin Chem; 1985 Nov; 31(11):1922-3. PubMed ID: 3902292
    [No Abstract]   [Full Text] [Related]  

  • 8. High-pressure liquid chromatographic determination of acetylsalicylic acid, salicylic acid, diflunisal, indomethacin, indoprofen and indobufen.
    Wåhlin-Boll E; Brantmark B; Hanson A; Melander A; Nilsson C
    Eur J Clin Pharmacol; 1981; 20(5):375-8. PubMed ID: 7286048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.
    Loewen GR; Herman RJ; Ross SG; Verbeeck RK
    Br J Clin Pharmacol; 1988 Jul; 26(1):31-9. PubMed ID: 3203058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro dissolution and in vivo bioavailability of diflunisal/naproxen fixed-dose combination tablets and concomitant administration of diflunisal and naproxen in healthy adult subjects.
    Helmy SA; El Bedaiwy HM
    Drug Res (Stuttg); 2013 Mar; 63(3):150-8. PubMed ID: 23444169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay methodology for quantification of the ester and ether glucuronide conjugates of diflunisal in human urine.
    Musson DG; Lin JH; Lyon KA; Tocco DJ; Yeh KC
    J Chromatogr; 1985 Feb; 337(2):363-78. PubMed ID: 3838756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference by diflunisal with the FETI method for serum thyroxine.
    Huisman JW
    Ann Clin Biochem; 1986 Mar; 23 ( Pt 2)():223-4. PubMed ID: 3532915
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesic.
    Verbeeck RK; Boel A; Buntinx A; De Schepper PJ
    Biochem Pharmacol; 1980 Feb; 29(4):571-6. PubMed ID: 7370051
    [No Abstract]   [Full Text] [Related]  

  • 14. Diflunisal cross-reactivity with the Trinder method for salicylate determination.
    Nordt SP
    Ann Pharmacother; 1996 Sep; 30(9):1041-2. PubMed ID: 8876878
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of alkaline diuresis to enhance diflunisal elimination.
    Balali-Mood M; Prescott LF
    Br J Clin Pharmacol; 1980 Aug; 10(2):163-5. PubMed ID: 7426277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diflunisal interference with determination of salicylate by the Trinder, Abbott TDx, and Du Pont aca methods.
    Dalrymple RW; Stearns FM
    Clin Chem; 1986 Jan; 32(1 Pt 1):230. PubMed ID: 3940724
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding.
    Verbeeck RK; De Schepper PJ
    Clin Pharmacol Ther; 1980 May; 27(5):628-35. PubMed ID: 7371361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential spectrophotometric, fluorimetric and high-performance liquid chromatographic determination of diflunisal and its tablets.
    Abdel-Hamid ME; Najib NM; Suleiman MS; el-Sayed YM
    Analyst; 1987 Nov; 112(11):1527-30. PubMed ID: 3439602
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversed-phase high-performance liquid chromatographic assay for the simultaneous determination of diflunisal and its glucuronides in serum and urine. Rearrangement of the 1-O-acylglucuronide.
    Hansen-Møller J; Dalgaard L; Hansen SH
    J Chromatogr; 1987 Sep; 420(1):99-109. PubMed ID: 3667833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial states.
    Tobert JA; DeSchepper P; Tjandramaga TB; Mullie A; Buntinx AP; Meisinger MA; Huber PB; Hall TL; Yeh KC
    Clin Pharmacol Ther; 1981 Sep; 30(3):385-9. PubMed ID: 7023791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.